

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.18916701 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45133418 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26941446 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.26941446 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 4.64248297 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.53958405 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.49971946 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47488569 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.46646219 |
| 10 | negative T cell selection (GO:0043383) | 4.41804250 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27958391 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.21490084 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.21490084 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.19372948 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.05508796 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.03935130 |
| 17 | T cell migration (GO:0072678) | 3.98845323 |
| 18 | detection of other organism (GO:0098543) | 3.88051812 |
| 19 | detection of bacterium (GO:0016045) | 3.84659429 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.84347496 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.79595145 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.74161374 |
| 23 | regulation of B cell differentiation (GO:0045577) | 3.73378751 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.63336934 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61314729 |
| 26 | B cell receptor signaling pathway (GO:0050853) | 3.56545513 |
| 27 | thymic T cell selection (GO:0045061) | 3.55475918 |
| 28 | T cell selection (GO:0045058) | 3.49640870 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48929930 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.48647692 |
| 31 | positive T cell selection (GO:0043368) | 3.46122226 |
| 32 | interferon-gamma production (GO:0032609) | 3.45832560 |
| 33 | response to interleukin-15 (GO:0070672) | 3.42790884 |
| 34 | germinal center formation (GO:0002467) | 3.42362394 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.40605754 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40191752 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.39985572 |
| 38 | positive regulation of humoral immune response (GO:0002922) | 3.36732355 |
| 39 | response to type I interferon (GO:0034340) | 3.33121753 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32058124 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.27884736 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.27526475 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.27526475 |
| 44 | positive regulation of granulocyte differentiation (GO:0030854) | 3.27234518 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 3.26566975 |
| 46 | mature B cell differentiation (GO:0002335) | 3.25162760 |
| 47 | leukocyte aggregation (GO:0070486) | 3.24736513 |
| 48 | myeloid dendritic cell activation (GO:0001773) | 3.22641006 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.21555626 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20372117 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 3.19442127 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18354739 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18354739 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18354739 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 3.18354739 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18354739 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.18354739 |
| 58 | positive regulation of interleukin-2 production (GO:0032743) | 3.16429535 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 3.15226062 |
| 60 | tolerance induction (GO:0002507) | 3.14431137 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11296922 |
| 62 | neutrophil activation (GO:0042119) | 3.10630537 |
| 63 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.09805703 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09781019 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09316414 |
| 66 | regulation of interferon-alpha production (GO:0032647) | 3.02808545 |
| 67 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.02722903 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99864768 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 2.96027645 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93101722 |
| 71 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93101722 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 2.92619088 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 2.91280932 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 2.88909401 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88893067 |
| 76 | granulocyte activation (GO:0036230) | 2.88020953 |
| 77 | microglial cell activation (GO:0001774) | 2.87769021 |
| 78 | defense response to protozoan (GO:0042832) | 2.87636491 |
| 79 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86917987 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86747954 |
| 81 | negative regulation of innate immune response (GO:0045824) | 2.86371775 |
| 82 | detection of biotic stimulus (GO:0009595) | 2.81457537 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 2.80675047 |
| 84 | detection of molecule of bacterial origin (GO:0032490) | 2.80531391 |
| 85 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.80093777 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80011791 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80011791 |
| 88 | mannose metabolic process (GO:0006013) | 2.79682452 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.78200013 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76943727 |
| 91 | T-helper 1 type immune response (GO:0042088) | 2.76428640 |
| 92 | macrophage activation involved in immune response (GO:0002281) | 2.76232826 |
| 93 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.75871961 |
| 94 | activated T cell proliferation (GO:0050798) | 2.75587612 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 2.73056116 |
| 96 | T cell homeostasis (GO:0043029) | 2.72924514 |
| 97 | macrophage activation (GO:0042116) | 2.71340360 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.71080951 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70579881 |
| 100 | regulation of granulocyte differentiation (GO:0030852) | 2.68648359 |
| 101 | mast cell activation (GO:0045576) | 2.68594028 |
| 102 | cellular response to zinc ion (GO:0071294) | 2.67712758 |
| 103 | T-helper cell differentiation (GO:0042093) | 2.67669982 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.67669982 |
| 105 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.67642270 |
| 106 | cellular extravasation (GO:0045123) | 2.67583783 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67310399 |
| 108 | Peyers patch development (GO:0048541) | 2.67177706 |
| 109 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.67177706 |
| 110 | B cell proliferation (GO:0042100) | 2.66542012 |
| 111 | response to protozoan (GO:0001562) | 2.66538308 |
| 112 | positive regulation of tolerance induction (GO:0002645) | 2.65786644 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.65111293 |
| 114 | natural killer cell activation (GO:0030101) | 2.64969465 |
| 115 | regulation of leukocyte degranulation (GO:0043300) | 2.64398279 |
| 116 | myeloid cell activation involved in immune response (GO:0002275) | 2.64114047 |
| 117 | lymph node development (GO:0048535) | 2.63266052 |
| 118 | respiratory burst (GO:0045730) | 2.62089057 |
| 119 | regulation of B cell proliferation (GO:0030888) | 2.61148421 |
| 120 | negative regulation of interleukin-12 production (GO:0032695) | 2.60340902 |
| 121 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60339582 |
| 122 | T cell costimulation (GO:0031295) | 2.59227560 |
| 123 | regulation of necroptotic process (GO:0060544) | 2.59182014 |
| 124 | regulation of tolerance induction (GO:0002643) | 2.58839297 |
| 125 | positive regulation of B cell proliferation (GO:0030890) | 2.58088593 |
| 126 | response to peptidoglycan (GO:0032494) | 2.57051861 |
| 127 | * lymphocyte homeostasis (GO:0002260) | 2.57004759 |
| 128 | positive regulation of B cell activation (GO:0050871) | 2.56833082 |
| 129 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.56579205 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55525004 |
| 131 | cellular response to interferon-beta (GO:0035458) | 2.55287096 |
| 132 | cellular response to exogenous dsRNA (GO:0071360) | 2.55238071 |
| 133 | lymphocyte costimulation (GO:0031294) | 2.54672555 |
| 134 | regulation of interleukin-12 production (GO:0032655) | 2.54114349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.17591293 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.97116596 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.80925387 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.28663258 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.07967348 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04310713 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34533885 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31838139 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27974609 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.20059392 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18760626 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.09656920 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88596854 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76451342 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.72249110 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65327018 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52163706 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41278602 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40562966 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.38311588 |
| 21 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24826387 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22020709 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.19719920 |
| 24 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18547631 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.13433532 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08331535 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.96468597 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88495005 |
| 29 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.88360553 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85016086 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.79527656 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.77858573 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71893585 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70314034 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69810478 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68750656 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64635396 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62665343 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61706169 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61563046 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56316436 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55674356 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53936717 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53636392 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53169825 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50669799 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49908964 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48363800 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47801625 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43567781 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39733315 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39237329 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38751436 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37051847 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35697324 |
| 56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34957408 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34934740 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34751568 |
| 59 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32742119 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30436256 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29919308 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28635070 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28585864 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27895506 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23572612 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21640047 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.20613449 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18644310 |
| 69 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.16523973 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16090352 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13421854 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12334153 |
| 73 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12132929 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11785579 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11622175 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10551277 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07246097 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06707876 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06168977 |
| 80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03905853 |
| 81 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.03535420 |
| 82 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.03063489 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01726612 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99955184 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96030446 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95393537 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93528351 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92091822 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90251413 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89689735 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89291251 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88447091 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87577988 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85924576 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84901917 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83616919 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83583739 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83200790 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82908863 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82152052 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82098117 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81483450 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80073116 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79525217 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79522281 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79077038 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77864225 |
| 108 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.76005472 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.75909602 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72987778 |
| 111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.72701687 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72573064 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69697751 |
| 114 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69236698 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.68322354 |
| 116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.67359549 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64610632 |
| 118 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64209544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35258653 |
| 2 | MP0000685_abnormal_immune_system | 3.56211282 |
| 3 | MP0005387_immune_system_phenotype | 3.32113692 |
| 4 | MP0001790_abnormal_immune_system | 3.32113692 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.13176372 |
| 6 | MP0005671_abnormal_response_to | 3.06601242 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.84441049 |
| 8 | MP0003436_decreased_susceptibility_to | 2.81780506 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.71966397 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.70590660 |
| 11 | MP0009785_altered_susceptibility_to | 2.67307793 |
| 12 | * MP0002723_abnormal_immune_serum | 2.61725065 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.57316099 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.56479383 |
| 15 | MP0005025_abnormal_response_to | 2.53198093 |
| 16 | * MP0002419_abnormal_innate_immunity | 2.51008280 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.46184039 |
| 18 | * MP0001819_abnormal_immune_cell | 2.45393514 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.41840030 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.37763093 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.22086437 |
| 22 | MP0004510_myositis | 2.18234685 |
| 23 | MP0002006_tumorigenesis | 2.16344526 |
| 24 | MP0002398_abnormal_bone_marrow | 2.11109842 |
| 25 | MP0001873_stomach_inflammation | 2.08728227 |
| 26 | MP0006082_CNS_inflammation | 2.07464136 |
| 27 | MP0001853_heart_inflammation | 2.06253530 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.05226587 |
| 29 | * MP0000716_abnormal_immune_system | 2.01984488 |
| 30 | MP0003724_increased_susceptibility_to | 1.98993584 |
| 31 | MP0003303_peritoneal_inflammation | 1.95647845 |
| 32 | MP0002405_respiratory_system_inflammati | 1.92216135 |
| 33 | MP0004947_skin_inflammation | 1.91488992 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.89720686 |
| 35 | MP0002254_reproductive_system_inflammat | 1.89564224 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.75796505 |
| 37 | * MP0010155_abnormal_intestine_physiology | 1.74878865 |
| 38 | * MP0001845_abnormal_inflammatory_respons | 1.72246302 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.67179715 |
| 40 | MP0002722_abnormal_immune_system | 1.66546085 |
| 41 | MP0005451_abnormal_body_composition | 1.65909435 |
| 42 | * MP0002429_abnormal_blood_cell | 1.61440465 |
| 43 | MP0005310_abnormal_salivary_gland | 1.57923770 |
| 44 | MP0002132_abnormal_respiratory_system | 1.41967435 |
| 45 | * MP0008469_abnormal_protein_level | 1.41878236 |
| 46 | MP0009764_decreased_sensitivity_to | 1.40850505 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.39365125 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.34747309 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.33084760 |
| 50 | MP0002933_joint_inflammation | 1.30464837 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.29423017 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.29218325 |
| 53 | MP0009278_abnormal_bone_marrow | 1.25247646 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.25150347 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.25130774 |
| 56 | MP0005360_urolithiasis | 1.23926662 |
| 57 | MP0002009_preneoplasia | 1.20609972 |
| 58 | MP0004381_abnormal_hair_follicle | 1.17348650 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.16086519 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.16086519 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.15688719 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.12205378 |
| 63 | MP0003866_abnormal_defecation | 1.11705990 |
| 64 | MP0003252_abnormal_bile_duct | 1.10486601 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.08917781 |
| 66 | MP0000858_altered_metastatic_potential | 1.08187459 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.06746165 |
| 68 | MP0003448_altered_tumor_morphology | 1.04867599 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.04488638 |
| 70 | MP0005365_abnormal_bile_salt | 1.03274515 |
| 71 | MP0009763_increased_sensitivity_to | 1.01862754 |
| 72 | MP0004883_abnormal_blood_vessel | 1.01077623 |
| 73 | MP0002928_abnormal_bile_duct | 0.99703647 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 0.98575117 |
| 75 | MP0003690_abnormal_glial_cell | 0.98396679 |
| 76 | MP0000371_diluted_coat_color | 0.97744500 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.96596909 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.92229179 |
| 79 | MP0004130_abnormal_muscle_cell | 0.88521498 |
| 80 | * MP0000609_abnormal_liver_physiology | 0.87147704 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.85521255 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.84502764 |
| 83 | MP0003045_fibrosis | 0.84464426 |
| 84 | MP0003279_aneurysm | 0.83967690 |
| 85 | MP0001851_eye_inflammation | 0.82855944 |
| 86 | MP0009840_abnormal_foam_cell | 0.81766571 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.81408673 |
| 88 | MP0001958_emphysema | 0.81204868 |
| 89 | MP0003075_altered_response_to | 0.79223020 |
| 90 | MP0000249_abnormal_blood_vessel | 0.72547047 |
| 91 | MP0003091_abnormal_cell_migration | 0.71230588 |
| 92 | MP0003646_muscle_fatigue | 0.70871297 |
| 93 | MP0005390_skeleton_phenotype | 0.70791775 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.68950045 |
| 95 | MP0005166_decreased_susceptibility_to | 0.68938627 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.68492450 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.68196971 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.68048488 |
| 99 | * MP0005164_abnormal_response_to | 0.67891299 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.67544022 |
| 101 | MP0000490_abnormal_crypts_of | 0.67206725 |
| 102 | MP0001879_abnormal_lymphatic_vessel | 0.64199972 |
| 103 | MP0003828_pulmonary_edema | 0.64036279 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.62158387 |
| 105 | MP0000604_amyloidosis | 0.61757753 |
| 106 | MP0000343_altered_response_to | 0.60366181 |
| 107 | MP0008260_abnormal_autophagy | 0.59818721 |
| 108 | MP0003795_abnormal_bone_structure | 0.57198355 |
| 109 | MP0002168_other_aberrant_phenotype | 0.57119316 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.56230088 |
| 111 | MP0001663_abnormal_digestive_system | 0.56167306 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.56005930 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.55911763 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.55842792 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.55411634 |
| 116 | MP0000383_abnormal_hair_follicle | 0.55163607 |
| 117 | MP0005023_abnormal_wound_healing | 0.55028178 |
| 118 | MP0008004_abnormal_stomach_pH | 0.50038926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.69425714 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.59717714 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.50786597 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.41128215 |
| 5 | Recurrent viral infections (HP:0004429) | 4.31688858 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.07986780 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.02313137 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 4.02313137 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.98873870 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.95358386 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.91410018 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.80235391 |
| 13 | Recurrent skin infections (HP:0001581) | 3.78711082 |
| 14 | Chronic otitis media (HP:0000389) | 3.77662872 |
| 15 | T lymphocytopenia (HP:0005403) | 3.68054029 |
| 16 | Myositis (HP:0100614) | 3.63463696 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.54741898 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50030012 |
| 19 | Vasculitis (HP:0002633) | 3.45313659 |
| 20 | Colitis (HP:0002583) | 3.42515522 |
| 21 | * Agammaglobulinemia (HP:0004432) | 3.40414172 |
| 22 | Meningitis (HP:0001287) | 3.37439368 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.33173700 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.27500816 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.25004486 |
| 26 | Gingival bleeding (HP:0000225) | 3.22742139 |
| 27 | Periodontitis (HP:0000704) | 3.17472413 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.10824065 |
| 29 | Abnormality of T cells (HP:0002843) | 3.09856923 |
| 30 | Stomatitis (HP:0010280) | 3.07681048 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.07648179 |
| 32 | Optic neuritis (HP:0100653) | 3.07648179 |
| 33 | Orchitis (HP:0100796) | 3.05979906 |
| 34 | Pustule (HP:0200039) | 2.98434421 |
| 35 | Gingivitis (HP:0000230) | 2.97015198 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.95538894 |
| 37 | Cellulitis (HP:0100658) | 2.94775319 |
| 38 | IgM deficiency (HP:0002850) | 2.87149003 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.86879221 |
| 40 | Gastrointestinal stroma tumor (HP:0100723) | 2.85615783 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.83587655 |
| 42 | Lymphopenia (HP:0001888) | 2.81599829 |
| 43 | Eosinophilia (HP:0001880) | 2.81061929 |
| 44 | Arterial thrombosis (HP:0004420) | 2.76426814 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74996473 |
| 46 | Epistaxis (HP:0000421) | 2.70904086 |
| 47 | Leukocytosis (HP:0001974) | 2.69126916 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.68472108 |
| 49 | Thyroiditis (HP:0100646) | 2.66484591 |
| 50 | Obstructive lung disease (HP:0006536) | 2.66343462 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66343462 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.65036530 |
| 53 | Myocardial infarction (HP:0001658) | 2.61846741 |
| 54 | Joint hemorrhage (HP:0005261) | 2.59015919 |
| 55 | Granulocytopenia (HP:0001913) | 2.56562905 |
| 56 | Abnormality of eosinophils (HP:0001879) | 2.52696272 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.52597525 |
| 58 | Osteomyelitis (HP:0002754) | 2.47642088 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.45967104 |
| 60 | * Chronic diarrhea (HP:0002028) | 2.41720925 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.40425194 |
| 62 | Hemoptysis (HP:0002105) | 2.39621451 |
| 63 | Encephalitis (HP:0002383) | 2.38429470 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.38385105 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38203603 |
| 66 | Nasal polyposis (HP:0100582) | 2.36951305 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.35410111 |
| 68 | Emphysema (HP:0002097) | 2.30845350 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.29964080 |
| 70 | Thrombocytosis (HP:0001894) | 2.29509112 |
| 71 | IgA deficiency (HP:0002720) | 2.28642388 |
| 72 | Increased IgE level (HP:0003212) | 2.27597109 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.26260900 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.23622055 |
| 75 | B lymphocytopenia (HP:0010976) | 2.23622055 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.22547595 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.21477500 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.20671214 |
| 79 | Hematochezia (HP:0002573) | 2.20574203 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.20299076 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.20008562 |
| 82 | IgG deficiency (HP:0004315) | 2.19028540 |
| 83 | Joint swelling (HP:0001386) | 2.17787045 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.14589988 |
| 85 | Abnormality of the prostate (HP:0008775) | 2.14266577 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.12847534 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11317705 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11317705 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11317705 |
| 90 | Mitral stenosis (HP:0001718) | 2.10500986 |
| 91 | Abnormality of the pleura (HP:0002103) | 2.09905879 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.09215112 |
| 93 | Hypochromic anemia (HP:0001931) | 2.08705012 |
| 94 | Chest pain (HP:0100749) | 2.07787336 |
| 95 | Premature loss of primary teeth (HP:0006323) | 2.03012966 |
| 96 | Increased IgM level (HP:0003496) | 2.02642173 |
| 97 | Pulmonary embolism (HP:0002204) | 2.01598287 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01515318 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01206782 |
| 100 | Viral hepatitis (HP:0006562) | 2.00924301 |
| 101 | Skin ulcer (HP:0200042) | 1.99801922 |
| 102 | Chronic sinusitis (HP:0011109) | 1.99399696 |
| 103 | Urticaria (HP:0001025) | 1.99032997 |
| 104 | Abnormal platelet function (HP:0011869) | 1.98720271 |
| 105 | Impaired platelet aggregation (HP:0003540) | 1.98720271 |
| 106 | Verrucae (HP:0200043) | 1.97216375 |
| 107 | Papilloma (HP:0012740) | 1.97216375 |
| 108 | Sepsis (HP:0100806) | 1.95941229 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 1.95748489 |
| 110 | Restrictive lung disease (HP:0002091) | 1.95085011 |
| 111 | Loss of speech (HP:0002371) | 1.92400455 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92305204 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92305204 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92305204 |
| 115 | Peritonitis (HP:0002586) | 1.91556453 |
| 116 | Fatigue (HP:0012378) | 1.91295469 |
| 117 | Papilledema (HP:0001085) | 1.90916734 |
| 118 | Spinal cord lesions (HP:0100561) | 1.90656498 |
| 119 | Syringomyelia (HP:0003396) | 1.90656498 |
| 120 | Abnormality of the peritoneum (HP:0002585) | 1.90296633 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.89799745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.28218583 |
| 2 | * MAP3K14 | 3.21230983 |
| 3 | TYK2 | 3.10059326 |
| 4 | TXK | 3.08978854 |
| 5 | JAK3 | 2.96157883 |
| 6 | BLK | 2.73123413 |
| 7 | IKBKE | 2.69688278 |
| 8 | IRAK4 | 2.56629550 |
| 9 | JAK1 | 2.40037271 |
| 10 | TBK1 | 2.34790362 |
| 11 | PRPF4B | 2.32909116 |
| 12 | KIT | 2.23770125 |
| 13 | FGFR4 | 2.06985543 |
| 14 | TRIB3 | 1.99413973 |
| 15 | IRAK3 | 1.93940556 |
| 16 | * IKBKB | 1.90324311 |
| 17 | BRD4 | 1.88172143 |
| 18 | ERN1 | 1.86850941 |
| 19 | STK10 | 1.82720640 |
| 20 | ZAP70 | 1.82132405 |
| 21 | TAOK3 | 1.78726177 |
| 22 | BTK | 1.71604981 |
| 23 | RIPK4 | 1.71497603 |
| 24 | ITK | 1.69601828 |
| 25 | SIK2 | 1.69342729 |
| 26 | CSF1R | 1.64695369 |
| 27 | TEC | 1.59985357 |
| 28 | TGFBR2 | 1.59128421 |
| 29 | FGFR3 | 1.53119713 |
| 30 | SYK | 1.51802164 |
| 31 | CSK | 1.50588354 |
| 32 | EPHA3 | 1.48715218 |
| 33 | SIK3 | 1.46081947 |
| 34 | EPHB1 | 1.45817865 |
| 35 | GRK6 | 1.41921046 |
| 36 | LCK | 1.39014405 |
| 37 | SIK1 | 1.38363306 |
| 38 | * CHUK | 1.38287880 |
| 39 | MAP3K10 | 1.36494935 |
| 40 | HCK | 1.31072236 |
| 41 | CDC42BPA | 1.26817708 |
| 42 | NLK | 1.26532525 |
| 43 | NEK9 | 1.22690282 |
| 44 | PASK | 1.11488771 |
| 45 | MARK3 | 1.11050648 |
| 46 | FLT3 | 1.09855175 |
| 47 | CAMKK1 | 1.06907658 |
| 48 | JAK2 | 1.06834941 |
| 49 | FGR | 1.06500563 |
| 50 | CDK12 | 1.04431823 |
| 51 | PIM1 | 1.01586218 |
| 52 | LYN | 1.01295974 |
| 53 | CAMK1D | 0.97359755 |
| 54 | PTK6 | 0.95461443 |
| 55 | MAP2K3 | 0.95413041 |
| 56 | * MAP3K7 | 0.94028001 |
| 57 | SMG1 | 0.92706392 |
| 58 | MAP3K1 | 0.90096697 |
| 59 | LRRK2 | 0.88711896 |
| 60 | PDK1 | 0.86799631 |
| 61 | MAP3K11 | 0.86603749 |
| 62 | CLK1 | 0.82977975 |
| 63 | RPS6KA4 | 0.80921731 |
| 64 | IRAK1 | 0.80710246 |
| 65 | MAP2K6 | 0.79564414 |
| 66 | FES | 0.78837630 |
| 67 | STK4 | 0.77688532 |
| 68 | * PRKCQ | 0.74244176 |
| 69 | INSRR | 0.73695094 |
| 70 | PDPK1 | 0.72121723 |
| 71 | CAMK1G | 0.70287543 |
| 72 | TAOK1 | 0.69408702 |
| 73 | FRK | 0.68760550 |
| 74 | MST4 | 0.65778058 |
| 75 | TRPM7 | 0.65734763 |
| 76 | MAP3K6 | 0.65342951 |
| 77 | MAP2K2 | 0.64997666 |
| 78 | CDK9 | 0.63174253 |
| 79 | TNK2 | 0.60791977 |
| 80 | EEF2K | 0.60273196 |
| 81 | MAPK11 | 0.59874241 |
| 82 | PKN1 | 0.59767840 |
| 83 | RPS6KC1 | 0.57728263 |
| 84 | RPS6KL1 | 0.57728263 |
| 85 | NUAK1 | 0.55441547 |
| 86 | GRK1 | 0.55131560 |
| 87 | CAMKK2 | 0.54770252 |
| 88 | PRKCH | 0.54493452 |
| 89 | SGK3 | 0.53017855 |
| 90 | CDK6 | 0.52877631 |
| 91 | CDK4 | 0.52263105 |
| 92 | ABL1 | 0.51459418 |
| 93 | MAPKAPK3 | 0.50753829 |
| 94 | EIF2AK2 | 0.49605436 |
| 95 | TTN | 0.47730352 |
| 96 | KSR2 | 0.45920381 |
| 97 | YES1 | 0.45381719 |
| 98 | HIPK2 | 0.44141601 |
| 99 | PDGFRB | 0.44096348 |
| 100 | MELK | 0.43135190 |
| 101 | RIPK1 | 0.42876653 |
| 102 | PKN2 | 0.42423311 |
| 103 | IRAK2 | 0.42091807 |
| 104 | MAPK7 | 0.41581819 |
| 105 | MATK | 0.40998870 |
| 106 | RET | 0.40708046 |
| 107 | RPS6KA2 | 0.40239700 |
| 108 | PIK3CG | 0.39788901 |
| 109 | SGK2 | 0.39070844 |
| 110 | * PRKAA2 | 0.38986101 |
| 111 | WNK1 | 0.38477654 |
| 112 | PTK2B | 0.36306801 |
| 113 | GRK7 | 0.35871885 |
| 114 | MAPK12 | 0.35624454 |
| 115 | IGF1R | 0.35465335 |
| 116 | EGFR | 0.35367673 |
| 117 | PRKCD | 0.34769025 |
| 118 | MAP3K3 | 0.34229474 |
| 119 | MAPK3 | 0.33266607 |
| 120 | PRKD2 | 0.33218956 |
| 121 | MAPKAPK2 | 0.32372704 |
| 122 | FYN | 0.32302321 |
| 123 | RPS6KA6 | 0.32159820 |
| 124 | BMPR2 | 0.30927554 |
| 125 | MAPK4 | 0.30233859 |
| 126 | MKNK2 | 0.29590464 |
| 127 | INSR | 0.29495728 |
| 128 | MARK2 | 0.26623514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62585754 |
| 2 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.13444586 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72894587 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58574004 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.49298175 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45482493 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38079000 |
| 8 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34216374 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32365773 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30488727 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.21612706 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18894945 |
| 13 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08897173 |
| 14 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93316961 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85606790 |
| 16 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83757970 |
| 17 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77511894 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.71932544 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71424994 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69989087 |
| 21 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.59258848 |
| 22 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.58339845 |
| 23 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.56199594 |
| 24 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55124132 |
| 25 | * Influenza A_Homo sapiens_hsa05164 | 1.54614787 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.43999153 |
| 27 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41579164 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.41242957 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.40934916 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37830828 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32927214 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.32583263 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31884872 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26220452 |
| 35 | * Apoptosis_Homo sapiens_hsa04210 | 1.20080784 |
| 36 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17140468 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.15767750 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12508490 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.08279262 |
| 40 | * Hepatitis B_Homo sapiens_hsa05161 | 1.06748861 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.06487143 |
| 42 | * Hepatitis C_Homo sapiens_hsa05160 | 1.06480338 |
| 43 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03295499 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01186036 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98824689 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97556680 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94361768 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93772015 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89685165 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89189700 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88986083 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86253651 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.85860108 |
| 54 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84137636 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80728236 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80424976 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79631381 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78794598 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76803728 |
| 60 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.76603246 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75529508 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75498769 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74897381 |
| 64 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.74823246 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72274740 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.69820934 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67580991 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67314341 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.66464708 |
| 70 | * Shigellosis_Homo sapiens_hsa05131 | 0.66392554 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64464529 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63050594 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62350514 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59834775 |
| 75 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59208492 |
| 76 | * Insulin resistance_Homo sapiens_hsa04931 | 0.57186285 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54998818 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54559543 |
| 79 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.54500835 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53229858 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51147964 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49982261 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.48267272 |
| 84 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47942308 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46718670 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46065135 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43743816 |
| 88 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42444523 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.41257682 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40642159 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40377960 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39195260 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38814031 |
| 94 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38740402 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38503097 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38018794 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36522973 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36004242 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35646078 |
| 100 | * Prostate cancer_Homo sapiens_hsa05215 | 0.35242077 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34763709 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34449962 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34125779 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33759713 |
| 105 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33459234 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33458047 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32914478 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32738888 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32714525 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32279171 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31965164 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.31777108 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29644178 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28942504 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.28791439 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.28311435 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25852846 |
| 118 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24616307 |
| 119 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24137834 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24108913 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23714556 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22991196 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.21973677 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21971619 |

